Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis

  Free Subscription


25.07.2022

1 Am J Gastroenterol
1 BMC Pediatr
1 Dig Dis Sci
1 Gastroenterology
3 Hepatology
1 Int J STD AIDS
6 J Hepatol
4 J Med Virol
1 J Viral Hepat
2 J Virol
1 JAMA
1 Minerva Gastroenterol (Torino)
4 PLoS One
1 PLoS Pathog
2 Proc Natl Acad Sci U S A
1 Z Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. WEINBERG EM, Dukewich M, Jakhete N, Stonesifer E, et al
    Early Liver Transplantation for Severe Alcohol-Associated Hepatitis and a History of Prior Liver Decompensation.
    Am J Gastroenterol. 2022 Jul 11. pii: 00000434-990000000-00432.
    PubMed         Abstract available


    BMC Pediatr

  2. HE Y, Zhou Y, Wang H, Peng X, et al
    The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B.
    BMC Pediatr. 2022;22:426.
    PubMed         Abstract available


    Dig Dis Sci

  3. RAMANI A, Tapper EB, Griffin C, Shankar N, et al
    Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07433.
    PubMed         Abstract available


    Gastroenterology

  4. KUSHNER T, Lange M, Sperling R, Dieterich D, et al
    Treatment of women with hepatitis C diagnosed in pregnancy: a co-located treatment approach.
    Gastroenterology. 2022 Jul 18. pii: S0016-5085(22)00789.
    PubMed        


    Hepatology

  5. ELSHEIKH R, Tien HT, Makram AM, Van NT, et al
    Acute Hepatitis of Unknown Origin in Children: Behind the Statistics.
    Hepatology. 2022 Jul 21. doi: 10.1002/hep.32682.
    PubMed         Abstract available

  6. PAPATHEODORIDI M, Lok AS, Papatheodoridis GV
    Letter to the Editor: Hepatitis B virus reactivation in immune checkpoint inhibitor-based combination therapies for hepatocellular carcinoma - Authors' reply.
    Hepatology. 2022 Jul 20. doi: 10.1002/hep.32673.
    PubMed        

  7. JIN ZC, Chen JJ, Luo B, Zhang WH, et al
    Letter to the Editor: Hepatitis B virus reactivation in immune checkpoint inhibitor-based combination therapies for hepatocellular carcinoma.
    Hepatology. 2022 Jul 15. doi: 10.1002/hep.32672.
    PubMed        


    Int J STD AIDS

  8. STENGAARD AR, Raben D, Leite RB, Seyler T, et al
    A call to action to reclaim focus on testing and early treatment for HIV, viral hepatitis, sexually transmitted infections and tuberculosis.
    Int J STD AIDS. 2022 Jul 15:9564624221107464. doi: 10.1177/09564624221107464.
    PubMed         Abstract available


    J Hepatol

  9. SEMMLER G, Meyer EL, Mandorfer M
    De-novo-HCC risk stratification after HCV-cure: All roads lead to Rome?
    J Hepatol. 2022 Jul 19. pii: S0168-8278(22)02944.
    PubMed        

  10. LIU SY, Yuan C, Tong XM
    Antiviral therapy, HBsAg seroclearance and late recurrence of Hepatitis B-related hepatocellular carcinoma.
    J Hepatol. 2022 Jul 18. pii: S0168-8278(22)02938.
    PubMed        

  11. DANDRI M, Volmari A, Lutgehetmann M
    The hepatitis delta virus and chronic hepatitis D.
    J Hepatol. 2022 Jul 15. pii: S0168-8278(22)00337.
    PubMed        

  12. PAPATHEODORIDIS GV, Lekakis V, Voulgaris T, Lampertico P, et al
    Hepatitis B Virus Reactivation Associated with New Classes of Immunosuppressants and Immunomodulators: A Systematic Review, Meta-analysis, and Expert Opinion.
    J Hepatol. 2022 Jul 15. pii: S0168-8278(22)02935.
    PubMed         Abstract available

  13. JORGENSEN MH, Cananzi M, Buescher G, Samyn M, et al
    Children with autoimmune liver disease have limited access to age-appropriate drug formulations, results from a European survey.
    J Hepatol. 2022;77:551-553.
    PubMed        

  14. WONG AM, Ding X, Wong AM, Xu M, et al
    Unique molecular characteristics of NAFLD-associated liver cancer accentuate beta-catenin/TNFRSF19-mediated immune evasion.
    J Hepatol. 2022;77:410-423.
    PubMed         Abstract available


    J Med Virol

  15. MALONGA GA, Dienta S, Traore FT, Maiga Z, et al
    Human Herpesvirus 8 seroprevalence among blood donors in Mali.
    J Med Virol. 2022 May 11. doi: 10.1002/jmv.27850.
    PubMed         Abstract available

  16. LIANG LY, Yip TC, Lai JC, Lam AS, et al
    Tenofovir alafenamide is associated with improved alanine aminotransferase and renal safety compared to tenofovir disoproxil fumarate.
    J Med Virol. 2022 May 17. doi: 10.1002/jmv.27863.
    PubMed         Abstract available

  17. LIAN J, Kuang W, Jia H, Lu Y, et al
    Pegylated interferon-alpha-2b combined with tenofovir disoproxil fumarate, granulocyte-macrophage colony-stimulating factor, and hepatitis B vaccine treatment for naive HBeAg-positive chronic hepatitis B patients: A prospective, multicenter, randomize
    J Med Virol. 2022 Jul 14. doi: 10.1002/jmv.28003.
    PubMed         Abstract available

  18. CHEEMA HA, Shahid A, Aziz H
    Severe acute pediatric hepatitis: the undue emphasis on adenovirus needs to be reassessed.
    J Med Virol. 2022 Jul 20. doi: 10.1002/jmv.28014.
    PubMed         Abstract available


    J Viral Hepat

  19. WANG H, Tong J, Xu X, Chen J, et al
    Reversibility of acute-on-chronic liver failure syndrome in hepatitis B virus-infected patients with and without prior decompensation.
    J Viral Hepat. 2022 Jul 6. doi: 10.1111/jvh.13732.
    PubMed         Abstract available


    J Virol

  20. HONG X, Hu J
    Conserved Lysine Residues of Hepatitis B Virus Core Protein Are Not Required for Covalently Closed Circular DNA Formation.
    J Virol. 2022 Jul 18:e0071822. doi: 10.1128/jvi.00718.
    PubMed         Abstract available

  21. CHEN Y, Yao Y, Zhao K, Liu C, et al
    DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.
    J Virol. 2022;96:e0058522.
    PubMed         Abstract available


    JAMA

  22. LARKIN HD
    As Unexplained Hepatitis Spreads, WHO Urges Action.
    JAMA. 2022;328:234.
    PubMed        


    Minerva Gastroenterol (Torino)

  23. WANG J
    Study on the value of testing five biochemical indexes of hepatitis B in patients with hepatitis B.
    Minerva Gastroenterol (Torino). 2022 Jul 15. pii: S2724-5985.22.03231.
    PubMed        


    PLoS One

  24. WOO HY, Heo J, Tak WY, Lee HJ, et al
    Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial.
    PLoS One. 2022;17:e0270716.
    PubMed         Abstract available

  25. WANG CH, Lin RC, Hsu HY, Tseng YT, et al
    Hormone replacement therapy is associated with reduced hepatocellular carcinoma risk and improved survival in postmenopausal women with hepatitis B: A nationwide long-term population-based cohort study.
    PLoS One. 2022;17:e0271790.
    PubMed         Abstract available

  26. SAHIBZADA KI, Ganova-Raeva L, Dimitrova Z, Ramachandran S, et al
    Hepatitis C virus transmission cluster among injection drug users in Pakistan.
    PLoS One. 2022;17:e0270910.
    PubMed         Abstract available

  27. MATA-MARIN JA, de Pablos-Leal AA, Mauss S, Arroyo-Anduiza CI, et al
    Risk factors for HCV transmission in HIV-positive men who have sex with men in Mexico.
    PLoS One. 2022;17:e0269977.
    PubMed         Abstract available


    PLoS Pathog

  28. CARTWRIGHT HN, Barbeau DJ, Doyle JD, Klein E, et al
    Genetic diversity of collaborative cross mice enables identification of novel rift valley fever virus encephalitis model.
    PLoS Pathog. 2022;18:e1010649.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  29. LI Y, Misumi I, Shiota T, Sun L, et al
    The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis.
    Proc Natl Acad Sci U S A. 2022;119:e2204511119.
    PubMed         Abstract available

  30. CHU JYK, Chuang YC, Tsai KN, Pantuso J, et al
    Autophagic membranes participate in hepatitis B virus nucleocapsid assembly, precore and core protein trafficking, and viral release.
    Proc Natl Acad Sci U S A. 2022;119:e2201927119.
    PubMed         Abstract available


    Z Gastroenterol

  31. KRUGER K, Rossol S, Krauth C, Buggisch P, et al
    Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R).
    Z Gastroenterol. 2022 Jul 15. doi: 10.1055/a-1852-5713.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: